Security key
76029N106
Replimune Group, Inc. - Common stock, par value $0.001 per share (REPL)
CUSIP: 76029N106
Q1 2019 13F Holders as of 31 Mar 2019
- Security type / class
- Equity / Common stock, par value $0.001 per share
- Total 13F shares
- 19,131,429
- Total 13F value
- $291,385,593
- Share change
- +972,860
- SEC-reported price per share
- $15.22
- Number of holders
- 53
- Value change
- +$17,749,806
- Number of buys
- 28
- Number of sells
- 12
- Shares outstanding
- 82,271,724
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q1 2019
Institutions
53
Top holders
10
REPL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2019
Previous quarter: Q4 2018
Replimune Group, Inc. SEC filings
Replimune Group, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 76029N106
Recent filing periods:
Ownership snapshot
Top reported holders of REPL - Replimune Group, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Omega Fund Management, LLC
Disclosed value leader
Omega Fund Management, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2018
13F
Lead comparable stake: 6.2%
Showing 1-6 of 15 holder rows.
Quick read
Omega Fund Management, LLC leads the comparable SEC ownership view at 6.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Omega Fund Management, LLC
6.2%
Bain Capital Life Sciences Invest...
3.5%
Redmile Group, LLC
2.7%
Foresite Capital Management IV, LLC
1.5%
BVF INC/IL
1.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Omega Fund Management, LLC |
13F
Company
|
6.2%
|
$51,035,000
5,103,455 shares
|
— | 31 Dec 2018 |
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
3.5%
|
$28,390,000
2,838,968 shares
|
— | 31 Dec 2018 |
| Redmile Group, LLC |
13F
Company
|
2.7%
|
$21,890,000
2,188,957 shares
|
— | 31 Dec 2018 |
| Foresite Capital Management IV, LLC |
13F
Company
|
1.5%
|
$12,297,000
1,229,656 shares
|
— | 31 Dec 2018 |
| BVF INC/IL |
13F
Company
|
1.1%
|
$8,996,000
899,617 shares
|
— | 31 Dec 2018 |
| Foresite Capital Management III, LLC |
13F
Company
|
0.95%
|
$7,797,000
779,656 shares
|
— | 31 Dec 2018 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
53
Shares
19,131,429
Rows available
53
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2019 vs Q4 2018 Across Filers
Q4 2018 holders
50
Q1 2019 holders
53
Holder diff
3
| Investor | Q4 2018 Shares | Q1 2019 Shares | Share Diff | Share Chg % | Q4 2018 value | Q1 2019 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend